[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584293":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":112,"collaborators":18,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":120,"eligibilityCriteria":121,"healthyVolunteers":116,"sex":122,"minAge":123,"maxAge":18,"enrollmentInfo":124,"targetDuration":18,"studyType":127,"phases":128,"briefSummary":130,"conditions":131,"keywords":18,"overallStatus":134,"whyStopped":18,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":144},{"fullName":5,"class":6},"VA Office of Research and Development","FED",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Pharmacist-Led","EXPERIMENTAL","Veterans will participate in regular telehealth visits with study pharmacists. Serum urate lab tests will be ordered during dose escalation phase of gout treatment.",[13],"Other: Pharmacist-Led",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care","NO_INTERVENTION","Veterans will receive standard care from their primary care provider for the management of their gout.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"OTHER","Pharmacist will conduct regular telehealth visits with Veterans during dose escalation phase of gout treatment",[9],[25],{"name":26,"affiliation":27,"role":28},"Ted R. Mikuls","Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Bridget Kramer","CONTACT","(402) 995-3206","bridget.kramer@va.gov",[36,52,68,83,97],{"facility":27,"status":18,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Omaha","Nebraska","68105-1850","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-95.94043,41.25626,{"lat":46,"lon":45},[49,51],{"name":31,"role":32,"phone":50,"phoneExt":18,"email":34},"402-995-3206",{"name":26,"role":28,"phone":18,"phoneExt":18,"email":18},{"facility":53,"status":18,"city":54,"state":55,"zip":56,"country":40,"countryCode":41,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"VA Portland Health Care System, Portland, OR","Portland","Oregon","97207-2964",{"type":43,"coordinates":58},[59,60],-122.67621,45.52345,{"lat":60,"lon":59},[63],{"name":64,"role":32,"phone":65,"phoneExt":66,"email":67},"Alexandra Bennett","503-220-8262","52472","alexandra.bennett@va.gov",{"facility":69,"status":18,"city":70,"state":71,"zip":72,"country":40,"countryCode":41,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA","Philadelphia","Pennsylvania","19104-4551",{"type":43,"coordinates":74},[75,76],-75.16362,39.95238,{"lat":76,"lon":75},[79],{"name":80,"role":32,"phone":81,"phoneExt":18,"email":82},"Criswell Lavery, MPH","215-823-5800","criswell.lavery@va.gov",{"facility":84,"status":18,"city":85,"state":86,"zip":87,"country":40,"countryCode":41,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"VA Salt Lake City Health Care System, Salt Lake City, UT","Salt Lake City","Utah","84148-0001",{"type":43,"coordinates":89},[90,91],-111.89105,40.76078,{"lat":91,"lon":90},[94],{"name":95,"role":32,"phone":18,"phoneExt":18,"email":96},"Jennifer Godina","jennifer.godina1@va.gov",{"facility":98,"status":18,"city":99,"state":100,"zip":101,"country":40,"countryCode":41,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"VA Puget Sound Health Care System Seattle Division, Seattle, WA","Seattle","Washington","98108-1532",{"type":43,"coordinates":103},[104,105],-122.33207,47.60621,{"lat":105,"lon":104},[108],{"name":109,"role":32,"phone":110,"phoneExt":18,"email":111},"Hannah Brubeck","206-764-2673","hannah.brubeck@va.gov",{"type":113,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100584293","pharmacist-led-treat-to-target-urate-lowering-therapy-in-patients-with-gout-100584293",false,"NCT06887452","Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout","Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients in Gout (Pharm-UP) Study","Pham-UP","Inclusion Criteria:\n\n* US Veterans over the age of 18 years with physician-diagnosed\n* Documented hyperuricemia (SU \\>6.8 mg\u002FdL)\n* Satisfy ACR\u002FEULAR gout classification criteria\n* Report 1 or more flares in the prior 6 months\n* Receipt of a new ULT prescription (allopurinol or febuxostat) initiated by a primary care provider or longer term ULT but otherwise satisfy the flare\u002FSU criteria\n\nExclusion Criteria:\n\n* Any patient intolerant or unable to take ULTs (allopurinol or febuxostat)\n* Patients with a rheumatology encounter within the prior 3 months","ALL","18 Years",{"count":125,"type":126},310,"ESTIMATED","INTERVENTIONAL",[129],"NA","This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.",[132,133],"Gout","Gouty Arthritis","NOT_YET_RECRUITING","2026-02-17",{"date":137,"type":138},"2026-02-19","ACTUAL",{"date":140,"type":126},"2026-10-01",{"date":142,"type":126},"2031-03-30",{"name":5,"class":6},5]